Study of pharmacokinetics of liposomal photosensitiser based on hydroxyaluminium tetra-3-phenylthiophthalocyanine on mice

The present work is devoted to the study of pharmacokinetics of infrared photosensitizer (PS) based on hydroxyaluminium tetra‑3‑phenylthiophthalocyanine in a sterically stabilized liposomal form. The study was carried out on adult female mice. The PS was administered once intravenously at a dose of...

Full description

Saved in:
Bibliographic Details
Main Authors: A. P. Budko, Z. G. Deichman, G. A. Meerovich, L. M. Borisova, I. G. Мeerovich, A. V. Lantsova, Kulbachevskaya N.Yu. Kulbachevskaya N.Yu. Kulbachevskaya N.Yu.
Format: Article
Language:Russian
Published: Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association" 2019-01-01
Series:Biomedical Photonics
Subjects:
Online Access:https://www.pdt-journal.com/jour/article/view/271
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850025324838912000
author A. P. Budko
Z. G. Deichman
G. A. Meerovich
L. M. Borisova
I. G. Мeerovich
A. V. Lantsova
Kulbachevskaya N.Yu. Kulbachevskaya N.Yu. Kulbachevskaya N.Yu.
author_facet A. P. Budko
Z. G. Deichman
G. A. Meerovich
L. M. Borisova
I. G. Мeerovich
A. V. Lantsova
Kulbachevskaya N.Yu. Kulbachevskaya N.Yu. Kulbachevskaya N.Yu.
author_sort A. P. Budko
collection DOAJ
description The present work is devoted to the study of pharmacokinetics of infrared photosensitizer (PS) based on hydroxyaluminium tetra‑3‑phenylthiophthalocyanine in a sterically stabilized liposomal form. The study was carried out on adult female mice. The PS was administered once intravenously at a dose of 6 mg / kg. Evaluation of the PS accumulation dynamics in the mice tissues and organs was performed at time intervals from 5 minutes to 7 days using spectral‑fluorescent method. The maximum accumulation of the PS photoactive form was recorded in lungs (32 µg / g in the interval of 5–30 minutes after introduction), liver (20.8 µg / g in the interval of 4–24 hours after introduction) and spleen (28 µg / g 4 hours after introduction). At the same time, by the end of the observation period (7 days after administration), trace amounts of the PS photoactive form were still detected in the liver and the spleen at a calculated concentration of 0.5‑1 µg / g. The PS accumulated the least in muscles and skin. The fluorescent signal from the PS accumulated in skin was detectable almost immediately, and its concentration remained at the same level (1.2‑1.5 µg / g) for up to 3 days of observation. In the muscles, the concentration of the PS reached 1.5 µg / g 15 minutes after administration, and then gradually decreased until 0.25 µg / g at 24 hours. Data on the pharmacokinetics of PS in blood, basic organs and tissues of animals were obtained, pharmacokinetic parameters were calculated. 7 days after the administration, the PS concentration in the skin and muscles was below the detection limit. The studies confrmed that PEGylation of the PS liposomal form slows down the process of its capture by reticulo‑endothelial system. It was shown that the PS circulates in blood and organs of mice for a long time and it completely distributes only when 4 hours pass after administration.
format Article
id doaj-art-e2fe4b2ea66e4ea4aef285762f16a300
institution DOAJ
issn 2413-9432
language Russian
publishDate 2019-01-01
publisher Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"
record_format Article
series Biomedical Photonics
spelling doaj-art-e2fe4b2ea66e4ea4aef285762f16a3002025-08-20T03:00:53ZrusNon-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"Biomedical Photonics2413-94322019-01-0174162210.24931/2413-9432-2018-7-4-16-22151Study of pharmacokinetics of liposomal photosensitiser based on hydroxyaluminium tetra-3-phenylthiophthalocyanine on miceA. P. Budko0Z. G. Deichman1G. A. Meerovich2L. M. Borisova3I. G. Мeerovich4A. V. Lantsova5Kulbachevskaya N.Yu. Kulbachevskaya N.Yu. Kulbachevskaya N.Yu.6N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow, Russia of the Ministry of Health of the Russian Federation, MoscowN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow, Russia of the Ministry of Health of the Russian Federation, MoscowProkhorov General Physics Institute of the Russian Academy of Sciences, Moscow; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), MoscowN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow, Russia of the Ministry of Health of the Russian Federation, MoscowBach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, MoscowN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow, Russia of the Ministry of Health of the Russian Federation, MoscowN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia, Moscow, Russia of the Ministry of Health of the Russian Federation, MoscowThe present work is devoted to the study of pharmacokinetics of infrared photosensitizer (PS) based on hydroxyaluminium tetra‑3‑phenylthiophthalocyanine in a sterically stabilized liposomal form. The study was carried out on adult female mice. The PS was administered once intravenously at a dose of 6 mg / kg. Evaluation of the PS accumulation dynamics in the mice tissues and organs was performed at time intervals from 5 minutes to 7 days using spectral‑fluorescent method. The maximum accumulation of the PS photoactive form was recorded in lungs (32 µg / g in the interval of 5–30 minutes after introduction), liver (20.8 µg / g in the interval of 4–24 hours after introduction) and spleen (28 µg / g 4 hours after introduction). At the same time, by the end of the observation period (7 days after administration), trace amounts of the PS photoactive form were still detected in the liver and the spleen at a calculated concentration of 0.5‑1 µg / g. The PS accumulated the least in muscles and skin. The fluorescent signal from the PS accumulated in skin was detectable almost immediately, and its concentration remained at the same level (1.2‑1.5 µg / g) for up to 3 days of observation. In the muscles, the concentration of the PS reached 1.5 µg / g 15 minutes after administration, and then gradually decreased until 0.25 µg / g at 24 hours. Data on the pharmacokinetics of PS in blood, basic organs and tissues of animals were obtained, pharmacokinetic parameters were calculated. 7 days after the administration, the PS concentration in the skin and muscles was below the detection limit. The studies confrmed that PEGylation of the PS liposomal form slows down the process of its capture by reticulo‑endothelial system. It was shown that the PS circulates in blood and organs of mice for a long time and it completely distributes only when 4 hours pass after administration.https://www.pdt-journal.com/jour/article/view/271photosensitizerpharmacokineticsfluorescence.
spellingShingle A. P. Budko
Z. G. Deichman
G. A. Meerovich
L. M. Borisova
I. G. Мeerovich
A. V. Lantsova
Kulbachevskaya N.Yu. Kulbachevskaya N.Yu. Kulbachevskaya N.Yu.
Study of pharmacokinetics of liposomal photosensitiser based on hydroxyaluminium tetra-3-phenylthiophthalocyanine on mice
Biomedical Photonics
photosensitizer
pharmacokinetics
fluorescence.
title Study of pharmacokinetics of liposomal photosensitiser based on hydroxyaluminium tetra-3-phenylthiophthalocyanine on mice
title_full Study of pharmacokinetics of liposomal photosensitiser based on hydroxyaluminium tetra-3-phenylthiophthalocyanine on mice
title_fullStr Study of pharmacokinetics of liposomal photosensitiser based on hydroxyaluminium tetra-3-phenylthiophthalocyanine on mice
title_full_unstemmed Study of pharmacokinetics of liposomal photosensitiser based on hydroxyaluminium tetra-3-phenylthiophthalocyanine on mice
title_short Study of pharmacokinetics of liposomal photosensitiser based on hydroxyaluminium tetra-3-phenylthiophthalocyanine on mice
title_sort study of pharmacokinetics of liposomal photosensitiser based on hydroxyaluminium tetra 3 phenylthiophthalocyanine on mice
topic photosensitizer
pharmacokinetics
fluorescence.
url https://www.pdt-journal.com/jour/article/view/271
work_keys_str_mv AT apbudko studyofpharmacokineticsofliposomalphotosensitiserbasedonhydroxyaluminiumtetra3phenylthiophthalocyanineonmice
AT zgdeichman studyofpharmacokineticsofliposomalphotosensitiserbasedonhydroxyaluminiumtetra3phenylthiophthalocyanineonmice
AT gameerovich studyofpharmacokineticsofliposomalphotosensitiserbasedonhydroxyaluminiumtetra3phenylthiophthalocyanineonmice
AT lmborisova studyofpharmacokineticsofliposomalphotosensitiserbasedonhydroxyaluminiumtetra3phenylthiophthalocyanineonmice
AT igmeerovich studyofpharmacokineticsofliposomalphotosensitiserbasedonhydroxyaluminiumtetra3phenylthiophthalocyanineonmice
AT avlantsova studyofpharmacokineticsofliposomalphotosensitiserbasedonhydroxyaluminiumtetra3phenylthiophthalocyanineonmice
AT kulbachevskayanyukulbachevskayanyukulbachevskayanyu studyofpharmacokineticsofliposomalphotosensitiserbasedonhydroxyaluminiumtetra3phenylthiophthalocyanineonmice